STOCK WATCH
Of late, textile scrips have lost their shine and are available at reasonable valuation. One such scrip is APM Industries (Code No: 523537) (Rs.42.30) which has cooled off from a high of Rs.75 to the current Rs.40. Its core business is manufacturing and marketing of synthetic blended yarn and it has recently enhanced its production capacity from 39,104 to 43,136 spindles. For the six month ending Sept 2005, it has already clocked an EPS of Rs.3.5 and it can report an EPS of Rs.8 on its current equity of 4.32 cr. for FY06. Trading at 65% discount to its book value and a PE multiple of just 5 times, it’s a pure value buy at current levels.
Sanjivani Parenteral (Code No: 531569) (Rs.54.30) has steadily progressed by manufacturing high quality medicines, mainly injectibles since 1998 for many reputed companies. Today, it has emerged as one of the biggest manufacturers of injectibles in the country. Its manufacturing facility is WHO GMP certified and is located at Taloja in Maharashtra and manufactures high grade antibiotics and life saving injectibles used in various pre and post-operative infections. Considering order book position for FY06, it can report Sales of Rs.45 cr. and NP of near Rs.7 cr. i.e. EPS of Rs.12 on its diluted equity of around Rs.6 cr. Inspite of such a strong growth story, its market cap is below Rs.30 cr. while it is discounted merely 4 times against its FY06 earning. A potential multibagger like Ankur Drugs!
Laffans Petro (Code No: 524522) (Rs.27.25) manufactures ethylene oxide derivatives such as Ethoxylates, Glycol Ethers, Acetates, Triethonal-amine, and Brake fluids. Due to higher demand and better price realisation of its products, it is expected to perform better in future. For FY05 ending 30th Sept 2005, its Sales grew by 30% to Rs.140 cr. whereas the NP doubled to Rs.4.30 cr. posting an EPS of Rs.5 on its small equity of Rs.8 cr. For FY06, the company is expected to report an EPS of more than Rs.6. Due to its low profit margin and rising raw material costs, the scrip is discounted very poorly on the bourses. But since the crude oil price has stabilized, its only matter of time for it to catch market fancy. With a book value of more than Rs.35 and 52 week high of Rs.40, the scrip is bound to cross Rs.50 in the coming mid-cap bull run.
After hitting a recent high of Rs.95, Kilburn Eng. (Code No: 522101) (Rs.59) has corrected sharply to just Rs.50 plus levels. It operates in areas of process design, engineering, manufacture, installation and commissioning of turnkey plants and systems catering to petrochemicals, chemicals, fertilisers, refineries, oil and gas and food processing. To improve its working capital requirement, the company is coming out with 1:1 rights issue at Rs.25 i.e. 50% discount to its CMP. For FY06 ending 30th Sept’06, it can report Sales of Rs.70 cr. and NP of Rs.8 cr. which means an EPS of Rs.6 on its expanded equity of Rs.13.50 cr. In spite of being in such a high growth sector, the scrip is cheaply discounted and overlooked by investors. A good long-term buy.
Investors have currently dumped metal scrips as the whole sector has lost its shine due to a fall in steel and other metal prices. But Sunflag Iron and Steel (Code No: 500404) (Rs.14.50) seems good scrip to accumulate in such a market condition for the long term. It has a modern state- of- the- art integrated steel plant with a capacity to produce over 2,00,000 MTA of high quality special steel as well as produce 1,50,000 MTA sponge iron Its product mix covers a wide range such as Carbon Special Steel, Alloy Steel, Free Cutting Steel, Ball Bearing Steel and Spring Steel. With an expected EPS of Rs.5 and 52 week high of Rs.27, this scrip has the potential to give 50% return in 12 months.
Another textile scrip, which is a good long-term bet, is Suryalata Spinning (Code No: 514138) (Rs.81.20). This south based manufacturer of cotton and blended yarn has capacity of 57,000 spindles. It is undergoing expansion to increase the capacity to 65,000 spindles and further by another 50,000 spindles over the next 2 years. It also intends to forward integrate itself into weaving and processing of fabric. For FY06, it can clock a turnover of Rs.175 cr. with NP of Rs.7.5 cr., which leads to an EPS of Rs.14 on its current equity of Rs.5.40 cr. Also, the company has made preferential allotment at Rs.88. Its share price can rise 50% in 6~9 months.
Sanjivani Parenteral (Code No: 531569) (Rs.54.30) has steadily progressed by manufacturing high quality medicines, mainly injectibles since 1998 for many reputed companies. Today, it has emerged as one of the biggest manufacturers of injectibles in the country. Its manufacturing facility is WHO GMP certified and is located at Taloja in Maharashtra and manufactures high grade antibiotics and life saving injectibles used in various pre and post-operative infections. Considering order book position for FY06, it can report Sales of Rs.45 cr. and NP of near Rs.7 cr. i.e. EPS of Rs.12 on its diluted equity of around Rs.6 cr. Inspite of such a strong growth story, its market cap is below Rs.30 cr. while it is discounted merely 4 times against its FY06 earning. A potential multibagger like Ankur Drugs!
Laffans Petro (Code No: 524522) (Rs.27.25) manufactures ethylene oxide derivatives such as Ethoxylates, Glycol Ethers, Acetates, Triethonal-amine, and Brake fluids. Due to higher demand and better price realisation of its products, it is expected to perform better in future. For FY05 ending 30th Sept 2005, its Sales grew by 30% to Rs.140 cr. whereas the NP doubled to Rs.4.30 cr. posting an EPS of Rs.5 on its small equity of Rs.8 cr. For FY06, the company is expected to report an EPS of more than Rs.6. Due to its low profit margin and rising raw material costs, the scrip is discounted very poorly on the bourses. But since the crude oil price has stabilized, its only matter of time for it to catch market fancy. With a book value of more than Rs.35 and 52 week high of Rs.40, the scrip is bound to cross Rs.50 in the coming mid-cap bull run.
After hitting a recent high of Rs.95, Kilburn Eng. (Code No: 522101) (Rs.59) has corrected sharply to just Rs.50 plus levels. It operates in areas of process design, engineering, manufacture, installation and commissioning of turnkey plants and systems catering to petrochemicals, chemicals, fertilisers, refineries, oil and gas and food processing. To improve its working capital requirement, the company is coming out with 1:1 rights issue at Rs.25 i.e. 50% discount to its CMP. For FY06 ending 30th Sept’06, it can report Sales of Rs.70 cr. and NP of Rs.8 cr. which means an EPS of Rs.6 on its expanded equity of Rs.13.50 cr. In spite of being in such a high growth sector, the scrip is cheaply discounted and overlooked by investors. A good long-term buy.
Investors have currently dumped metal scrips as the whole sector has lost its shine due to a fall in steel and other metal prices. But Sunflag Iron and Steel (Code No: 500404) (Rs.14.50) seems good scrip to accumulate in such a market condition for the long term. It has a modern state- of- the- art integrated steel plant with a capacity to produce over 2,00,000 MTA of high quality special steel as well as produce 1,50,000 MTA sponge iron Its product mix covers a wide range such as Carbon Special Steel, Alloy Steel, Free Cutting Steel, Ball Bearing Steel and Spring Steel. With an expected EPS of Rs.5 and 52 week high of Rs.27, this scrip has the potential to give 50% return in 12 months.
Another textile scrip, which is a good long-term bet, is Suryalata Spinning (Code No: 514138) (Rs.81.20). This south based manufacturer of cotton and blended yarn has capacity of 57,000 spindles. It is undergoing expansion to increase the capacity to 65,000 spindles and further by another 50,000 spindles over the next 2 years. It also intends to forward integrate itself into weaving and processing of fabric. For FY06, it can clock a turnover of Rs.175 cr. with NP of Rs.7.5 cr., which leads to an EPS of Rs.14 on its current equity of Rs.5.40 cr. Also, the company has made preferential allotment at Rs.88. Its share price can rise 50% in 6~9 months.
No comments:
Post a Comment